Novo Nordisk A/S (NONOF)
37.39
+0.06
(+0.15%)
USD |
OTCM |
Oct 06, 16:00
Novo Nordisk Price : 37.39 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 34.81 | 37.63 | 34.81 | 37.39 | 412575.0 |
| Oct 05, 2026 | 37.52 | 37.52 | 36.26 | 37.34 | 14768.00 |
| Oct 02, 2026 | 37.95 | 38.44 | 36.69 | 37.01 | 14285.00 |
| Oct 01, 2026 | 35.86 | 38.36 | 35.86 | 37.38 | 11125.00 |
| Sep 30, 2026 | 38.01 | 38.53 | 37.91 | 38.15 | 11176.00 |
| Sep 29, 2026 | 38.08 | 38.77 | 38.01 | 38.34 | 85378.00 |
| Sep 28, 2026 | 37.44 | 38.85 | 37.44 | 38.38 | 11179.00 |
| Sep 25, 2026 | 38.42 | 39.23 | 38.42 | 38.66 | 9735.00 |
| Sep 24, 2026 | 38.41 | 38.75 | 38.10 | 38.40 | 1.007M |
| Sep 23, 2026 | 39.54 | 39.54 | 36.40 | 38.25 | 15790.00 |
| Sep 22, 2026 | 39.50 | 40.04 | 39.01 | 39.32 | 6521.00 |
| Sep 21, 2026 | 41.69 | 41.69 | 39.54 | 39.92 | 107889.0 |
| Sep 18, 2026 | 42.34 | 43.33 | 42.06 | 42.62 | 747264.0 |
| Sep 17, 2026 | 42.69 | 42.98 | 40.00 | 42.00 | 3507.00 |
| Sep 16, 2026 | 42.00 | 42.57 | 41.56 | 41.56 | 6006.00 |
| Sep 15, 2026 | 42.21 | 43.26 | 41.94 | 42.42 | 225264.0 |
| Sep 14, 2026 | 41.21 | 44.26 | 41.21 | 43.67 | 5124.00 |
| Sep 11, 2026 | 43.93 | 43.93 | 42.00 | 43.19 | 14651.00 |
| Sep 10, 2026 | 44.56 | 45.39 | 42.98 | 44.14 | 12753.00 |
| Sep 09, 2026 | 45.76 | 45.76 | 43.51 | 44.47 | 3462.00 |
| Sep 08, 2026 | 43.15 | 46.30 | 43.15 | 45.44 | 10568.00 |
| Sep 04, 2026 | 43.88 | 47.00 | 43.88 | 46.31 | 1840.00 |
| Sep 03, 2026 | 45.56 | 47.50 | 45.50 | 46.50 | 7400.00 |
| Sep 02, 2026 | 46.50 | 47.55 | 45.02 | 46.85 | 11552.00 |
| Sep 01, 2026 | 45.01 | 46.59 | 44.85 | 45.35 | 9289.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1191.50 |
| ALK-Abello A/S | 31.00 |
| H. Lundbeck A/S | 6.40 |
| AstraZeneca PLC | 160.28 |
| Dr. Reddy's Laboratories Ltd. | 12.30 |
Price Related Metrics
| PE Ratio | 9.139 |
| PS Ratio | 3.231 |
| PEG Ratio | 0.7253 |
| Price to Book Value | 4.884 |
| Price to Free Cash Flow | 22.56 |
| Earnings Yield | 10.94% |
| Market Cap | 165.31B |
| PEGY Ratio | 0.5247 |
| Operating PE Ratio | 7.120 |
| Normalized PE Ratio | 8.784 |